ad

Dr. Agarwal’s Health Care Share Price Outlook: Where Could It Be by 2030?

Dr. Agarwal’s Health Care share price Rs 494. 52W high Rs 568, low Rs 401. Market cap Rs 15,653 Cr. 2030 scenario range Rs 540 to Rs 890.


16 Jul 202612:30 pm

Dr. Agarwal’s Health Care Share Price Outlook: Where Could It Be by 2030?

The Dr. Agarwal’s Health Care share price forecast for the next 3 years is a question on many investors’ minds as the stock trades at Rs 494, within a 52 week range of Rs 401 to Rs 568. This article lays out a scenario based Dr. Agarwal’s Health Care share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Dr. Agarwal’s Health Care Company Overview

Dr. Agarwal’s Health Care operates India’s largest chain of eye care hospitals and clinics, providing cataract, refractive and other ophthalmic surgical and diagnostic services across India and select international markets. Understanding the business model is the first step in framing any credible Dr. Agarwal’s Health Care share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company Dr. Agarwal’s Health Care
NSE Ticker AGARWALEYE
CMP Rs 494
52 Week High Rs 568
52 Week Low Rs 401
Market Cap Rs 15,653 Cr
Stock PE 118
Book Value Rs 63.9
ROE 6.81%
ROCE 11.1%
Dividend Yield 0%

Where Does Dr. Agarwal’s Health Care Share Price Stand Today?

The stock currently trades about 13 percent below its 52 week high of Rs 568, which means the market has already tempered some of its optimism. For anyone building a Dr. Agarwal’s Health Care share price forecast, this correction matters for the Dr. Agarwal’s Health Care share price forecast starting point, because entry valuations have a large bearing on 3 year returns.

At the current price, Dr. Agarwal’s Health Care commands a market capitalisation of Rs 15,653 Cr and trades at a price to earnings multiple of 118. The company generates a return on equity of 6.81% and a return on capital employed of 11.1%, which places it in the category of businesses with a recovering profitability profile. These numbers anchor the Dr. Agarwal’s Health Care share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Dr. Agarwal’s Health Care Share Price Forecast: Key Growth Drivers for the Next 3 Years

Four forces are likely to shape the Dr. Agarwal’s Health Care share price forecast between now and 2030, and together they explain most of the dispersion in this Dr. Agarwal’s Health Care share price forecast. Each is discussed below with its likely direction of impact.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. With a recovering profitability profile at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Dr. Agarwal’s Health Care share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Healthcare Services Demand Tailwinds

Rising insurance penetration, lifestyle disease burden and medical tourism keep Indian hospital demand growing in double digits. Organised chains like Dr. Agarwal’s Health Care with strong clinical brands can add beds profitably for years.

Within the space, investors often benchmark Dr. Agarwal’s Health Care against peers such as Krishna Institute of Medical Sciences, Global Health and Artemis Medicare Services on growth and valuations before forming a view on the Dr. Agarwal’s Health Care share price forecast.

Company Specific Catalysts

The bull case for Dr. Agarwal’s Health Care rests on rising demand for organised eye care services, ageing population driving cataract surgery volumes and clinic network expansion. If these play out on schedule, the Dr. Agarwal’s Health Care share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Dr. Agarwal’s Health Care share price forecast, while global risk aversion would do the opposite to the Dr. Agarwal’s Health Care share price outlook.

Dr. Agarwal’s Health Care Share Price Forecast 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Dr. Agarwal’s Health Care share price forecast using compounded annual growth assumptions applied to the current market price of Rs 494. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year Bear Case Base Case Bull Case Assumption
2027 Rs 510 Rs 555 Rs 600 2% to 14% CAGR on CMP
2028 Rs 520 Rs 600 Rs 685 2% to 14% CAGR on CMP
2030 Rs 540 Rs 700 Rs 890 2% to 14% CAGR on CMP

In the base case scenario of this Dr. Agarwal’s Health Care share price forecast, the 2030 level works out to roughly Rs 700, implying steady compounding from today’s levels. The bull case of Rs 890 assumes rising demand for organised eye care services delivers ahead of expectations, while the bear case of Rs 540 captures a scenario where growth stalls. That is an outcome band of about 9 percent to 80 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Bull Case vs Bear Case for Dr. Agarwal’s Health Care Share Price

The Bull Case

The optimistic Dr. Agarwal’s Health Care share price forecast assumes rising demand for organised eye care services, ageing population driving cataract surgery volumes and clinic network expansion. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 890 by 2030.

The Bear Case

The cautious view centres on the fact that new clinic ramp up costs and competition from other organised eye care chains are key risks. If these pressures dominate, the Dr. Agarwal’s Health Care share price forecast would skew toward the lower band and the stock could stagnate near Rs 540 even by 2030, underperforming broader indices.

Key Risks That Could Change the Dr. Agarwal’s Health Care Share Price Outlook

  • Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Dr. Agarwal’s Health Care share price forecast.
  • Valuation risk: At a PE of 118, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
  • Sector risk: New clinic ramp up costs and competition from other organised eye care chains are key risks.
  • Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
  • Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.

Is Dr. Agarwal’s Health Care Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Dr. Agarwal’s Health Care share price forecast lands in 2030 or what any single Dr. Agarwal’s Health Care share price forecast says today, but whether the business can compound capital through cycles. The company’s positioning around rising demand for organised eye care services gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Dr. Agarwal’s Health Care share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Dr. Agarwal’s Health Care share price live.

Conclusion

The Dr. Agarwal’s Health Care share price forecast for the next 3 years spans Rs 540 to Rs 890 by 2030 under the scenarios discussed, with a base case near Rs 700. Any credible Dr. Agarwal’s Health Care share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising demand for organised eye care services and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What is the Dr. Agarwal’s Health Care share price forecast for the next 3 years?

Ans. The Dr. Agarwal’s Health Care share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 540 in the bear case to Rs 890 in the bull case, with a base case near Rs 700, depending on earnings delivery and market conditions.

What is the Dr. Agarwal’s Health Care share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 510 to Rs 600, with a base case around Rs 555. This assumes compounding on the current price of Rs 494 and is illustrative, not a guaranteed outcome.

What is the Dr. Agarwal’s Health Care share price forecast for 2028?

Ans. The 2028 scenario range is Rs 520 to Rs 685, with the base case near Rs 600. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Dr. Agarwal’s Health Care?

Ans. Dr. Agarwal’s Health Care currently trades at around Rs 494 on the NSE, within a 52 week range of Rs 401 to Rs 568. Prices change continuously during market hours, so check live quotes before acting.

Is Dr. Agarwal’s Health Care a good stock for the long term?

Ans. Dr. Agarwal’s Health Care has a credible long term story built on rising demand for organised eye care services, but it also carries risks since new clinic ramp up costs and competition from other organised eye care chains are key risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Dr. Agarwal’s Health Care share price outlook for 2030?

Ans. The Dr. Agarwal’s Health Care share price outlook for 2030 spans Rs 540 to Rs 890 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Dr. Agarwal’s Health Care share price forecast?

Ans. The main risks are execution delays, valuation compression from the current PE of 118, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down